Vimarsana
Biggest News Aggregation in the World

Page 28 - Sam Runyon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sam Runyon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sam Runyon Today - Breaking & Trending Today

Senate Dems revive talks to score wins by passing spending bill with party-line vote - Vimarsana News

Senate Dems revive talks to score wins by passing spending bill with party-line vote

Senate Democrats are reviving negotiations on a budget reconciliation bill in hopes of scoring some modest wins out of President Biden's derailed social welfare and climate agenda.

Supreme Court siding with WV against EPA unlikely to stop coal's long decline - Vimarsana News

Supreme Court siding with WV against EPA unlikely to stop coal's long decline

It was a vision of new power for West Virginia rising out of the ashes for all coming into the state to see.

2 Democrat Senators Dash Biden's Hopes to End Filibuster to Pass Abortion Bills - Vimarsana News

2 Democrat Senators Dash Biden's Hopes to End Filibuster to Pass Abortion Bills

Sens. Joe Manchin (D-W.Va.) and Kyrsten Sinema (D-Ariz.) dashed the Biden administration's hopes that the Senate would vote ...

Anger, praise, hope on Hill after Supreme Court EPA ruling - Vimarsana News

Anger, praise, hope on Hill after Supreme Court EPA ruling

"It's less consequential for the Biden administration than it might appear," said Sen. Sheldon Whitehouse (D-R.I.) about the West Virginia v. EPA ruling.

Source: eenews.net
Sen. Majority Leader Chuck Schumer to revitalize prescription drug reform legislation in July - Vimarsana News

Sen. Majority Leader Chuck Schumer to revitalize prescription drug reform legislation in July

If the drug measures pass muster with the parliamentarian, Democrats will have set up a popular bill to let Medicare negotiate specific drug prices, lower premiums for lower-income Medicare recipients, cap out-of-pocket costs at $2,000 a year, and institute rebates for inflation.